Clinical Trial Update: A Study of Denosumab in Multiple Myeloma Patients With Renal Insufficiency [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating denosumab in patients with multiple myeloma and renal insufficiency has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Denosumab (denosumab)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED